nach oben

Erschienen in:

2019 | OriginalPaper | Buchkapitel

8. Targeted Therapeutic Nanoparticles for Cancer and Other Human Diseases

verfasst von : Rabiatul Basria S. M. N. Mydin, Wan Nordiana Rahman, Rosmazihana Mat Lazim, Amirah Mohd Gazzali, Nur Hazirah Mohd Azlan, Said Moshawih

Erschienen in: Nanotechnology: Applications in Energy, Drug and Food

Verlag: Springer International Publishing

Einloggen

Aktivieren Sie unsere intelligente Suche, um passende Fachinhalte oder Patente zu finden.

search-config

KI-gestützte Suche

Aus

Abstract

Targeted drug delivery is a useful approach to enhanced the present therapeutic efficacy in treating human diseases especially cancers. Nanoparticles is known for its ability to act as passive targeting agent through the enhanced permeability and retention effects and it has also shown promising results for drug or gene delivery, radiotherapy and photodynamic therapy applications. This chapter will describe the different organic and inorganic therapeutic nanoparticles that may be used with specific applications. These materials will be explained in brief alongside the reported research works and its related applications.

Sie haben noch keine Lizenz? Dann Informieren Sie sich jetzt über unsere Produkte:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

über 102.000 Bücher
über 537 Zeitschriften

aus folgenden Fachgebieten:

Automobil + Motoren
Bauwesen + Immobilien
Business IT + Informatik
Elektrotechnik + Elektronik
Energie + Nachhaltigkeit
Finance + Banking
Management + Führung
Marketing + Vertrieb
Maschinenbau + Werkstoffe
Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Jetzt informieren

Springer Professional "Technik"

Online-Abonnement

Mit Springer Professional "Technik" erhalten Sie Zugriff auf:

über 67.000 Bücher
über 390 Zeitschriften

aus folgenden Fachgebieten:

Automobil + Motoren
Bauwesen + Immobilien
Business IT + Informatik
Elektrotechnik + Elektronik
Energie + Nachhaltigkeit
Maschinenbau + Werkstoffe

Jetzt Wissensvorsprung sichern!

Jetzt informieren

Vorheriges Kapitel Nanotechnology-Based Drug Delivery Systems: Past, Present and Future

Nächstes Kapitel Solid Lipid Nanoparticles: A Modern Approach for the Treatment of Neurodegenerative Diseases

Abrahamse H, Hamblin MR (2016) New photosensitizers for photodynamic therapy. Biochem J 473(4):347–364PubMedCrossRef

Bachor R, Shea CR, Belmonte SJ, Hasan T (1991) Free and conjugated chlorin E6 in the photodynamic therapy of human bladder carcinoma cells. J Urol 146(6):1654–1658PubMedCrossRef

Ban C, Jo M, Lim S, Choi YJ (2018) Control of the gastrointestinal digestion of solid lipid nanoparticles using PEGylated emulsifiers. Food Chem 239:442–452PubMedCrossRef

Banerjee A, Qi J, Gogoi R, Wong J, Mitragotri S (2016) Role of nanoparticle size, shape and surface chemistry in oral drug delivery. J Control Release 238:176–185PubMedPubMedCentralCrossRef

Bharathiraja S, Moorthy MS, Manivasagan P, Seo H, Lee KD, Oh J (2017) Chlorin e6 conjugated silica nanoparticles for targeted and effective photodynamic therapy. Photodiagn Photodyn Ther 19:212–220CrossRef

Bovis MJ, Woodhams JH, Loizidou M, Scheglmann D, Bown SG, MacRobert AJ (2012) Improved in vivo delivery of m-THPC via pegylated liposomes for use in photodynamic therapy. J Control Release 157(2):196–205PubMedCrossRef

Brannon-Peppas L, Blanchette JO (2004) Nanoparticle and targeted systems for cancer therapy. Adv Drug Deliv Rev 56(11):1649–1659PubMedCrossRef

Brede C, Labhasetwar V (2013) Applications of nanoparticles in the detection and treatment of kidney diseases. Adv Chronic Kidney Dis 20(6):454–465PubMedCrossRef

Cacciatore I, Ciulla M, Fornasari E, Marinelli L, Di Stefano A (2016) Solid lipid nanoparticles as a drug delivery system for the treatment of neurodegenerative diseases. Expert Opin Drug Deliv 13(8):1121–1131PubMedCrossRef

Cassim SM, Giustini AJ, Petryk AA, Strawbridge RA, Hoopes PJ (2009) Iron oxide hyperthermia and radiation cancer treatment. Proc SPIE Int Soc Opt Eng 181:71810O

Cecchelli R, Berezowski V, Lundquist S, Culot M, Renftel M, Dehouck MP, Fenart L (2007) Modelling of the blood–brain barrier in drug discovery and development. Nat Rev Drug Discov 6(8):650–661PubMedCrossRef

Chen C, Ke J, Zhou XE, Yi W, Brunzelle JS, Li J et al (2013) Structural basis for molecular recognition of folic acid by folate receptors. Nature 500(7463):486–489PubMedPubMedCentralCrossRef

Cho K, Wang XU, Nie S, Shin DM (2008) Therapeutic nanoparticles for drug delivery in cancer. Clin Cancer Res 14(5):1310–1316PubMedCrossRef

Colombeau L, Acherar S, Baros F, Arnoux P, Gazzali AM, Zaghdoudi K et al (2016) Inorganic nanoparticles for photodynamic therapy. In: Sortino S (ed) Light-responsive nanostructured systems for applications in nanomedicine. Springer International Publishing, Cham, pp 113–134CrossRef

Davis ME, Shin DM (2008) Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat Rev Drug Discov 7(9):771–782PubMedCrossRef

Dikmen G, Genç L, Güney G (2011) Advantage and disadvantage in drug delivery systems. J Mater Sci Eng 5(4):468

Esposito E, Mariani P, Ravani L, Contado C, Volta M, Bido S et al (2012) Nanoparticulate lipid dispersions for bromocriptine delivery: characterization and in vivo study. Eur J Pharm Biopharm 80(2):306–314PubMedCrossRef

Fu Y, Liu H, Ren Z, Li X, Huang J, Best S, Han G (2017) Luminescent CaTiO 3: Yb, Er nanofibers co-conjugated with Rose Bengal and gold nanorods for potential synergistic photodynamic/photothermal therapy. J Mater Chem B 5(26):5128–5136CrossRefPubMed

Fundarò A, Cavalli R, Bargoni A, Vighetto D, Zara GP, Gasco MR (2000) Non-stealth and stealth solid lipid nanoparticles (SLN) carrying doxorubicin: pharmacokinetics and tissue distribution after iv administration to rats. Pharmacol Res 42(4):337–343PubMedCrossRef

Gao S, Wang J, Tian R, Wang G, Zhang L, Li Y et al (2017) Construction and evaluation of a targeted hyaluronic acid nanoparticle/photosensitizer complex for cancer photodynamic therapy. ACS Appl Mater Interfaces 9(38):32509–32519PubMedCrossRef

Gelperina S, Kisich K, Iseman MD, Heifets L (2005) The potential advantages of nanoparticle drug delivery systems in chemotherapy of tuberculosis. Am J Respir Crit Care Med 172(12):1487–1490PubMedPubMedCentralCrossRef

Gupta AK, Gupta M (2005) Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials 26(18):3995–4021PubMedCrossRef

Gupta AK, Wells S (2004) Surface-modified superparamagnetic nanoparticles for drug delivery: preparation, characterization, and cytotoxicity studies. IEEE Trans Nanobioscience 3(1):66–73PubMedCrossRef

Hainfeld JF, Slatkin DN, Smilowitz HM (2004) The use of gold nanoparticles to enhance radiotherapy in mice. Phys Med Biol 49(18):N309PubMedCrossRef

Hood JD, Bednarski M, Frausto R, Guccione S, Reisfeld RA, Xiang R, Cheresh DA (2002) Tumor regression by targeted gene delivery to the neovasculature. Science 296(5577):2404–2407PubMedCrossRef

Hsu SH, Wen CJ, Al-Suwayeh SA, Chang HW, Yen TC, Fang JY (2010) Physicochemical characterization and in vivo bioluminescence imaging of nanostructured lipid carriers for targeting the brain: apomorphine as a model drug. Nanotechnology 21(40):405101PubMedCrossRef

Huang G, Chen H, Dong Y, Luo X, Yu H, Moore Z et al (2013) Superparamagnetic iron oxide nanoparticles: amplifying ROS stress to improve anticancer drug efficacy. Theranostics 3(2):116PubMedPubMedCentralCrossRef

Kaur IP, Bhandari R, Bhandari S, Kakkar V (2008) Potential of solid lipid nanoparticles in brain targeting. J Control Release 127(2):97–109PubMedCrossRef

Khan I, Saeed K, Khan I (2017) Nanoparticles: properties, applications and toxicities. Arab J Chem In Press

Kievit FM, Zhang M (2011) Surface engineering of iron oxide nanoparticles for targeted cancer therapy. Acc Chem Res 44(10):853–862PubMedPubMedCentralCrossRef

Kim HR, Gil S, Andrieux K, Nicolas V, Appel M, Chacun H et al (2007) Low-density lipoprotein receptor-mediated endocytosis of PEGylated nanoparticles in rat brain endothelial cells. Cell Mol Life Sci 64(3):356–364PubMedCrossRef

Kim JK, Seo SJ, Kim KH, Kim TJ, Chung MH, Kim KR, Yang TK (2010) Therapeutic application of metallic nanoparticles combined with particle-induced x-ray emission effect. Nanotechnology 21(42):425102PubMedCrossRef

Klein S, Sommer A, Distel LV, Hazemann JL, Kröner W, Neuhuber W et al (2014) Superparamagnetic iron oxide nanoparticles as novel X-ray enhancer for low-dose radiation therapy. J Phys Chem B 118(23):6159–6166PubMedCrossRef

Kuo YC, Cheng SJ (2016) Brain targeted delivery of carmustine using solid lipid nanoparticles modified with tamoxifen and lactoferrin for antitumor proliferation. Int J Pharm 499(1):10–19PubMedCrossRef

Kuo YC, Hong TY (2014) Delivering etoposide to the brain using catanionic solid lipid nanoparticles with surface 5-HT-moduline. Int J Pharm 465(1):132–142PubMedCrossRef

Kuo YC, Lee CH (2015) Inhibition against growth of glioblastoma multiforme in vitro using etoposide-loaded solid lipid nanoparticles with p-Aminophenyl-α-d-Manno-Pyranoside and folic acid. J Pharm Sci 104(5):1804–1814PubMedCrossRef

Kuo YC, Liang CT (2011) Inhibition of human brain malignant glioblastoma cells using carmustine-loaded catanionic solid lipid nanoparticles with surface anti-epithelial growth factor receptor. Biomaterials 32(12):3340–3350PubMedCrossRef

Kuo YC, Shih-Huang CY (2014) Solid lipid nanoparticles with surface antibody for targeting the brain and inhibiting lymphatic phagocytosis. J Taiwan Inst Chem Eng 45(4):1154–1163CrossRef

Kuo YC, Wang IH (2017) Using catanionic solid lipid nanoparticles with wheat germ agglutinin and lactoferrin for targeted delivery of etoposide to glioblastoma multiforme. J Taiwan Inst Chem Eng 77:73–82CrossRef

Kwatra D, Venugopal A, Anant S (2013) Nanoparticles in radiation therapy: a summary of various approaches to enhance radiosensitization in cancer. Transl Cancer Res 2(4):330–342

Lamprecht A (ed) (2016) Nanotherapeutics: drug delivery concepts in nanoscience. CRC Press, Boca Raton, FL

Lévy R, Shaheen U, Cesbron Y, See V (2010) Gold nanoparticles delivery in mammalian live cells: a critical review. Nano Rev 1(1):4889CrossRef

Li L, Mak KY, Shi J, Koon HK, Leung CH, Wong CM et al (2012) Comparative in vitro cytotoxicity study on uncoated magnetic nanoparticles: effects on cell viability, cell morphology, and cellular uptake. J Nanosci Nanotechnol 12(12):9010–9017PubMedCrossRef

Lin X, Yan SZ, Qi SS, Xu Q, Han SS, Guo LY et al (2017) Transferrin-modified nanoparticles for photodynamic therapy enhance the antitumor efficacy of Hypocrellin A. Front Pharmacol 8:815PubMedPubMedCentralCrossRef

Liu KS, Wen CJ, Yen TC, Sung KC, Ku MC, Wang JJ, Fang JY (2012) Combined strategies of apomorphine diester prodrugs and nanostructured lipid carriers for efficient brain targeting. Nanotechnology 23(9):095103PubMedCrossRef

Liu J, Meng T, Yuan M, Wen L, Cheng B, Liu N et al (2016) MicroRNA-200c delivered by solid lipid nanoparticles enhances the effect of paclitaxel on breast cancer stem cell. Int J Nanomedicine 11:6713PubMedPubMedCentralCrossRef

Mäder K, Mehnert W (2004) 1—solid lipid nanoparticles—concepts, procedures, and physicochemical aspects. In: Nastruzzi C (ed) Lipospheres in drug targets and delivery: approaches, methods, and applications. CRC Press, Boca Raton, FL, pp 1–22

Mahmoudi M, Simchi A, Imani M, Milani AS, Stroeve P (2008) Optimal design and characterization of superparamagnetic iron oxide nanoparticles coated with polyvinyl alcohol for targeted delivery and imaging. J Phys Chem B 112(46):14470–14481PubMedCrossRef

Mahmoudi M, Simchi A, Milani AS, Stroeve P (2009) Cell toxicity of superparamagnetic iron oxide nanoparticles. J Colloid Interface Sci 336(2):510–518PubMedCrossRef

Mahmoudi M, Simchi A, Imani M, Shokrgozar MA, Milani AS, Häfeli UO, Stroeve P (2010) A new approach for the in vitro identification of the cytotoxicity of superparamagnetic iron oxide nanoparticles. Colloids Surf B: Biointerfaces 75(1):300–309PubMedCrossRef

Maier-Hauff K, Ulrich F, Nestler D, Niehoff H, Wust P, Thiesen B et al (2011) Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiforme. J Neuro-Oncol 103(2):317–324CrossRef

Malekigorji M, Curtis ADM, Hoskins C (2014) The use of iron oxide nanoparticles for pancreatic cancer therapy. J Nanomed Res 1:1

Martinez AI, Garcia-Lobato MA, Perry DL (2009) Study of the properties of iron oxide nanostructures. Res Nanotechnol Devel 19:184–193

Martín-Rapun R, De Matteis L, Ambrosone A, Garcia-Embid S, Gutierrez L, De La Fuente M, J. (2017) Targeted nanoparticles for the treatment of Alzheimer’s disease. Curr Pharm Des 23:1927–1952PubMedCrossRef

Matsudaira H, Ueno AM, Furuno I (1980) Iodine contrast medium sensitizes cultured mammalian cells to X rays but not to γ rays. Radiat Res 84(1):144–148PubMedCrossRef

Mello RS, Callisen H, Winter J, Kagan AR, Norman A (1983) Radiation dose enhancement in tumors with iodine. Med Phys 10(1):75–78CrossRef

Mishra BBTS, Patel BB, Tiwari S (2010) Colloidal nanocarriers: a review on formulation technology, types and applications toward targeted drug delivery. Nanomedicine 6(1):9–24PubMedCrossRef

Mudshinge SR, Deore AB, Patil S, Bhalgat CM (2011) Nanoparticles: emerging carriers for drug delivery. Saudi Pharm J 19:129–141PubMedPubMedCentralCrossRef

Pardeshi CV, Rajput PV, Belgamwar VS, Tekade AR, Surana SJ (2013) Novel surface modified solid lipid nanoparticles as intranasal carriers for ropinirole hydrochloride: application of factorial design approach. Drug Deliv 20(1):47–56PubMedCrossRef

Rahman WN, Bishara N, Ackerly T, He CF, Jackson P, Wong C et al (2009) Enhancement of radiation effects by gold nanoparticles for superficial radiation therapy. Nanomedicine 5(2):136–142PubMedCrossRef

Reddy LH, Sharma RK, Chuttani K, Mishra AK, Murthy RSR (2005) Influence of administration route on tumor uptake and biodistribution of etoposide loaded solid lipid nanoparticles in Dalton’s lymphoma tumor bearing mice. J Control Release 105(3):185–198CrossRef

Rosen JE, Chan L, Shieh DB, Gu FX (2012) Iron oxide nanoparticles for targeted cancer imaging and diagnostics. Nanomedicine 8(3):275–290PubMedCrossRef

Rosenkranz AA, Jans DA, Sobolev AS (2000) Targeted intracellular delivery of photosensitizers to enhance photodynamic efficiency. Immunol Cell Biol 78(4):452–464PubMedCrossRef

Rui LL, Cao HL, Xue YD, Liu LC, Xu L, Gao Y, Zhang WA (2016) Functional organic nanoparticles for photodynamic therapy. Chin Chem Lett 27(8):1412–1420CrossRef

Seo SJ, Jeon JK, Jeong EJ, Chang WS, Choi GH, Kim JK (2013) Enhancement of tumor regression by coulomb nanoradiator effect in proton treatment of iron-oxide nanoparticle-loaded orthotopic rat glioma model: implication of novel particle induced radiation therapy. J Cancer Ther 4(11):25CrossRef

Shah B, Khunt D, Bhatt H, Misra M, Padh H (2015) Application of quality by design approach for intranasal delivery of rivastigmine loaded solid lipid nanoparticles: effect on formulation and characterization parameters. Eur J Pharm Sci 78:54–66PubMedCrossRef

Shin TH, Choi Y, Kim S, Cheon J (2015) Recent advances in magnetic nanoparticle-based multi-modal imaging. Chem Soc Rev 44(14):4501–4516PubMedCrossRef

Singh R, Lillard JW (2009) Nanoparticle-based targeted drug delivery. Exp Mol Pathol 86:215–223PubMedPubMedCentralCrossRef

Soenen SJ, De Cuyper M, De Smedt SC, Braeckmans K (2012) Investigating the toxic effects of iron oxide nanoparticles. Methods Enzymol 509:195–224PubMedCrossRef

Song Y, Shi Q, Zhu C, Luo Y, Lu Q, Li H et al (2017) Mitochondrial-targeted multifunctional mesoporous Au@ Pt nanoparticles for dual-mode photodynamic and photothermal therapy of cancers. Nanoscale 9(41):15813–15824PubMedCrossRef

Spiers FW (1949) The influence of energy absorption and electron range on dosage in irradiated bone. Br J Radiol 22(261):521–533PubMedCrossRef

Steichen SD, Caldorera-Moore M, Peppas NA (2013) A review of current nanoparticle and targeting moieties for the delivery of cancer therapeutics. Eur J Pharm Sci 48:416–427PubMedCrossRef

Su XY, Liu PD, Wu H, Gu N (2014) Enhancement of radiosensitization by metal-based nanoparticles in cancer radiation therapy. Cancer Biol Med 11(2):86PubMedPubMedCentral

Sutradhar KB, Amin ML (2014) Nanotechnology in cancer drug delivery and selective targeting. ISRN Nanotechnol 2014:1–12CrossRef

Toossi MTB, Ghorbani M, Sabet LS, Akbari F, Mehrpouyan M (2015) A Monte Carlo study on dose enhancement and photon contamination production by various nanoparticles in electron mode of a medical linac. Nukleonika 60(3):489–496CrossRef

Tsai MJ, Huang YB, Wu PC, Fu YS, Kao YR, Fang JY, Tsai YH (2011) Oral apomorphine delivery from solid lipid nanoparticles with different monostearate emulsifiers: pharmacokinetic and behavioral evaluations. J Pharm Sci 100(2):547–557PubMedCrossRef

Urbanski M, Mirzaei J, Sharma A, Hofmann D, Kitzerow H-S, Hegmann T (2016) Chemically and thermally stable, emissive carbon dots as viable alternatives to semiconductor quantum dots for emissive nematic liquid crystal–nanoparticle mixtures with lower threshold voltage. Liq Cryst 43:183–194CrossRef

Veiseh O, Gunn JW, Zhang M (2010) Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging. Adv Drug Deliv Rev 62(3):284–304PubMedCrossRef

Wen CJ, Zhang LW, Al-Suwayeh SA, Yen TC, Fang JY (2012) Theranostic liposomes loaded with quantum dots and apomorphine for brain targeting and bioimaging. Int J Nanomedicine 7:1599PubMedPubMedCentral

Wennink JW, Liu Y, Mäkinen PI, Setaro F, de la Escosura A, Bourajjaj M et al (2017) Macrophage selective photodynamic therapy by meta-tetra (hydroxyphenyl) chlorin loaded polymeric micelles: a possible treatment for cardiovascular diseases. Eur J Pharm Sci 107:112–125PubMedCrossRef

Westman JA (2006) Medical genetics for the modern clinician. Lippincott Williams & Wilkins, Philadelphia, PA

Wong HL, Bendayan R, Rauth AM, Wu XY (2004) Development of solid lipid nanoparticles containing ionically complexed chemotherapeutic drugs and chemosensitizers. J Pharm Sci 93(8):1993–2008PubMedCrossRef

Wong HL, Bendayan R, Rauth AM, Wu XY (2006a) Simultaneous delivery of doxorubicin and GG918 (Elacridar) by new polymer-lipid hybrid nanoparticles (PLN) for enhanced treatment of multidrug-resistant breast cancer. J Control Release 116(3):275–284PubMedCrossRef

Wong HL, Rauth AM, Bendayan R, Manias JL, Ramaswamy M, Liu Z et al (2006b) A new polymer–lipid hybrid nanoparticle system increases cytotoxicity of doxorubicin against multidrug-resistant human breast cancer cells. Pharm Res 23(7):1574–1585PubMedCrossRef

Wu W, He Q, Jiang C (2008) Magnetic iron oxide nanoparticles: synthesis and surface functionalization strategies. Nanoscale Res Lett 3(11):397PubMedPubMedCentralCrossRef

Wu J, Han H, Jin Q, Li Z, Li H, Ji J (2017) Design and proof of programmed 5-aminolevulinic acid prodrug nanocarriers for targeted photodynamic cancer therapy. ACS Appl Mater Interfaces 9(17):14596–14605PubMedCrossRef

Xie L, Jiang R, Zhu F, Liu H, Ouyang G (2014) Application of functionalized magnetic nanoparticles in sample preparation. Anal Bioanal Chem 406(2):377–399PubMedCrossRef

Yang SC, Lu LF, Cai Y, Zhu JB, Liang BW, Yang CZ (1999) Body distribution in mice of intravenously injected camptothecin solid lipid nanoparticles and targeting effect on brain. J Control Release 59(3):299–307PubMedCrossRef

Youssef Z, Vanderesse R, Colombeau L, Baros F, Roques-Carmes T, Frochot C et al (2017) The application of titanium dioxide, zinc oxide, fullerene, and graphene nanoparticles in photodynamic therapy. Cancer Nanotechnol 8(1):6PubMedPubMedCentralCrossRef

Yusuf M, Khan M, Khan RA, Ahmed B (2013) Preparation, characterization, in vivo and biochemical evaluation of brain targeted Piperine solid lipid nanoparticles in an experimentally induced Alzheimer’s disease model. J Drug Target 21(3):300–311CrossRefPubMed

Zara GP, Cavalli R, Bargoni A, Fundarò A, Vighetto D, Gasco MR (2002) Intravenous administration to rabbits of non-stealth and stealth doxorubicin-loaded solid lipid nanoparticles at increasing concentrations of stealth agent: pharmacokinetics and distribution of doxorubicin in brain and other tissues. J Drug Target 10(4):327–335PubMedCrossRef

Titel: Targeted Therapeutic Nanoparticles for Cancer and Other Human Diseases
verfasst von: Rabiatul Basria S. M. N. Mydin
Wan Nordiana Rahman
Rosmazihana Mat Lazim
Amirah Mohd Gazzali
Nur Hazirah Mohd Azlan
Said Moshawih
Verlag: Springer International Publishing
Buch: Nanotechnology: Applications in Energy, Drug and Food
Print ISBN: 978-3-319-99601-1

Electronic ISBN: 978-3-319-99602-8

Copyright-Jahr: 2019
DOI: https://doi.org/10.1007/978-3-319-99602-8_8